No other medication is as cost-effective as aspirin for preventing cardiovascular events. However, it must be understood that low-dose aspirin is not completely harmless, as “low-dose” may imply.
Read More »Diabetes In Control
Cholesterol Levels: Diet Vs. Genes
No matter what their lifestyle, people’s genes play an overriding role in their cholesterol response, according to a new study.
Read More »Physicians Are Slow to Step Up Treatment For Patients With High A1cs
A recent Canadian study examined administrative records of diabetic patients to see if specialists or primary care physicians gave them better care.
Read More »“Patient Navigator” Legislation Will Help Expand Access to Diabetes Prevention a
Recently-enacted legislation, strongly backed by the American Diabetes Association, will improve outreach and coordination of health care services for chronically ill, uninsured patients in low-income and rural areas.
Read More »Obese Men Cannot Process Carbs as Efficiently as obese Women
Because obese men may not process carbohydrates as efficiently as obese women, it ultimately, leads to a decrease in fitness level and the development of metabolic disorders.
Read More »Pioglitazone and Rosiglitazone Have Different Effects on Lipids
Advantage goes to pioglitazone, according to the results of a large head to head comparison.
Read More »Rosiglitazone Safe in Diabetics With Elevated Liver Enzymes
Diabetic patients with elevated baseline liver enzymes are not at increased risk of hepatotoxicity from treatment with the thiazolidinedione rosiglitazone,
Read More »Metabolic Syndrome Increases Stroke Risk in Elderly
Metabolic syndrome in elderly subjects is associated with an increased risk for acute ischemic/nonembolic stroke, according to a new study.
Read More »Cardiovascular Fitness Inversely Linked to Risk of Metabolic Syndrome
Higher fitness levels provide 63% protection against metabolic syndrome even in individuals with increased susceptibility because of existing metabolic risk factors.
Read More »BiDil, The First Racially Targeted Medication For BP Has A Controversial Pricing
The new BP medication made up of isosorbide dinitrate and hydralazine has been approved for use in black patients. The brand will sell for 6-10 dollars per daily dose, but cost less then a dime.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.